Guru Ownership Trend
Guru Analysis for Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.05 M.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.95 M net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 17.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Zentalis Pharmaceuticals, Inc. (ZNTL)
Major holders include Renaissance Technologies (RenTech) ($7.8 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 1.61 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.95 M, with 0 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 3 fully exited ZNTL. The total reported sell value was $1.95 M.
No tracked managers opened new positions or increased their holdings in ZNTL during the most recent reporting period.